Dianthus Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline LUCY Q1 2026 Earnings EPS Surprises with a 2282 Beat Despite Missing Revenue Details WBD Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress in Turnaround RIME Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Surges Quoin Pharmaceuticals Ltd Q1 2026 Earnings NarrowerThanExpected Loss Amid PreRevenue Phase Satellos Bioscience Q1 2026 Earnings Narrower Loss Reported Stock Slips on Lack of Revenue Progress